Course
and credit requirements have changed for current part-time M.B.A.
students (enrolled prior to fall 2017) who have opted to
switch to the new 54-credit curriculum. Please visit this page for a full breakdown of adjusted curriculum requirements for the 54-credit part-time M.B.A.
Rutgers Business School: Graduate Programs-Newark and New Brunswick offers a leading M.B.A. program for health care, pharmaceutical, and biotech professionals, an education bolstered by the school's proximity and its connections to the hub of industry activity in New Jersey.
The Rutgers M.B.A. in pharmaceutical management was recently recognized as one of the top 10 programs in the world by Find-MBA.com. Classes are taught by academic experts, including Professor Michael Santoro, as well as former top industry executives like Thomas Gorrie, who held positions in the upper echelons of management at Johnson & Johnson.
Rutgers Business School (RBS) partners with such companies as Bayer, Bristol-Myers Squibb, Eisai, Johnson & Johnson, and Novartis to provide M.B.A. students focused on pharmaceutical management with distinct advantages. The partnerships help to support a prestigious industry scholars program that provides scholarships to cover in- or out-of-state tuition for eligible students, offers meaningful internship opportunities, and enhances employment prospects with industry giants.
The Rutgers M.B.A. in pharmaceutical management, which was developed with full participation of top industry executives, is a 60-credit master of business administration, including 18 credits in pharmaceutical industry and pharmaceutical marketing. Elective courses in the concentration are open to all students enrolled at RBS.
Contact information
Mahmud
Hassan, Director
1 Washington Park, 1164
973-353-5386
